SCHEMBL23975901

SCHEMBL23975901

CCN(C)c1nc(Cl)nc2c1CCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
LMNA P02545 3/20 0.39
ABCB1 P08183 2/20 0.37
TUBB3 Q13509 2/20 0.37
GAA P10253 4/20 0.36
CYP1A2 P05177 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 2/20 0.33
POLB P06746 1/20 0.33
ADRB2 P07550 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
MAPK1 P28482 3/20 0.32
ACHE P22303 1/20 0.32
BPTF Q12830 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CACNA2D1 P54289 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6456837 0.80 L3MBTL1 (0.50) L3MBTL1LMNAABCB1TUBB3GAA
SCHEMBL30118652 0.80 GAA (0.36) L3MBTL1LMNAABCB1TUBB3GAA
SCHEMBL23975966 0.80 GAA (0.36) L3MBTL1LMNAABCB1TUBB3GAA
SCHEMBL30225145 0.78 ACHE (0.38) LMNAABCB1TUBB3GAACYP1A2
SCHEMBL23976664 0.78 ABCB1 (0.33) L3MBTL1LMNAABCB1TUBB3GAA
SCHEMBL23975725 0.78 ACHE (0.38) LMNAABCB1TUBB3GAACYP1A2
SCHEMBL23975849 0.77 USP2 (0.32) L3MBTL1LMNAABCB1TUBB3GAA
SCHEMBL30225350 0.74 GAA (0.38) L3MBTL1LMNAGAACYP1A2TSHR
SCHEMBL23975730 0.74 POLB (0.40) L3MBTL1LMNAGAACYP1A2ALDH1A1
SCHEMBL23975870 0.74 USP2 (0.35) L3MBTL1LMNAABCB1TUBB3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed